UK markets close in 2 hours 50 minutes

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,460.56+4.16 (+0.29%)
As of 1:24PM BST. Market open.
Full screen
Loading interactive chart…
  • China's Clover says its coronavirus vaccine candidate showed promise in animal test
    Reuters

    China's Clover says its coronavirus vaccine candidate showed promise in animal test

    An experimental coronavirus vaccine developed by China's Clover Biopharmaceuticals appeared to be safe and able to trigger immune responses in animal tests, researchers have said. The result of the study on monkeys comes months after Clover began an early stage human trial in Australia in June, as global drug makers race to develop a safe and effective vaccine that can protect people from the COVID-19 pandemic that has killed nearly 1 million people. Clover's vaccine candidate, which is partly funded by a global vaccine research coalition, uses adjuvants, ingredients that could boost immune responses, from Britain's GlaxoSmithKline and U.S.-based Dynavax Technologies.

  • Pharma Stock Roundup: J&J's Coronavirus Vaccine in Phase III, Other Updates
    Zacks

    Pharma Stock Roundup: J&J's Coronavirus Vaccine in Phase III, Other Updates

    J&J (JNJ) becomes the fourth company to start a phase III study on its coronavirus vaccine candidate. CHMP recommends approval of several drugs.

  • Sanofi/Glaxo to Supply 70M Coronavirus Vaccine Doses in Canada
    Zacks

    Sanofi/Glaxo to Supply 70M Coronavirus Vaccine Doses in Canada

    Sanofi's (SNY) recombinant protein-based technology is being combined with Glaxo's pandemic adjuvant technology to develop an adjuvanted COVID-19 vaccine.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more